Related Experiment Video

Updated: Aug 19, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine

Robert C Brunham1, José Rey-Ladino

  • 1University of British Columbia Centre for Disease Control, Vancouver, British Columbia V5Z 4R4, Canada. Robert.Brunham@bccdc.ca

Nature Reviews. Immunology
|February 3, 2005
PubMed

Insights

Chlamydia trachomatis infections are a global health issue. Research on mouse models advances our understanding of immunity, aiding vaccine development for this common bacterial sexually transmitted disease.

Area of Science:

  • Immunology
  • Microbiology
  • Public Health

Background:

  • Sexually transmitted Chlamydia trachomatis infections represent a significant global public health challenge, with over 90 million annual cases.
  • C. trachomatis is the leading cause of bacterial sexually transmitted infections worldwide.
  • Advances in understanding Chlamydia muridarum infection in mice provide a valuable model for human C. trachomatis infections.

Purpose of the Study:

  • To review the current understanding of the immune response to Chlamydia species infections.
  • To explore how this knowledge can enhance the development of a vaccine against C. trachomatis.

Main Methods:

  • Literature review of immunological studies on Chlamydia infections.
  • Analysis of findings from Chlamydia muridarum mouse models.
  • Integration of immunological data to inform vaccine development strategies.

Main Results:

  • Elucidation of the immunobiology of Chlamydia muridarum infection in mice has provided insights into human C. trachomatis immunity.
  • A common model of immunity for Chlamydia infections has been developed.
  • Progress in understanding immune responses is improving prospects for a C. trachomatis vaccine.

Conclusions:

  • Understanding the immune response to Chlamydia spp. is crucial for combating sexually transmitted infections.
  • The development of a vaccine against C. trachomatis is becoming more feasible due to advancements in immunological research.
  • Continued research into Chlamydia immunobiology holds promise for effective prevention strategies.

More Related Videos

Forward Genetic Approaches in Chlamydia trachomatis09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Related Concept Videos

Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.